2009 "Leadership in Innovation" Award Winner
Patrick Soon-Shiong, MD, Executive Chairman of Abraxis Bioscience, and Chairman and CEO of Abraxis Health, has achieved international acclaim as a scientist, surgeon, visionary and philanthropist. Abraxis Health is a fully-integrated, next-generation, evidenced-based, personalized healthcare company dedicated to the discovery, development, validation and clinical application of diagnostics and therapeutics that are tailored to the specific molecular profile of patients, in order to offer safer and more effective treatments for cancer and other critical illnesses. Earlier, as CEO of Abraxis Bioscience, Patrick developed the first FDA-approved protein nanoparticle delivery technology for the treatment of metastatic breast cancer -- ABRAXANE, which is now being developed to treat lung, melanoma, gastric and pancreatic cancer. Also, Patrick recently launched The National Coalition for Health Integration, a non-profit, public-private coalition working to create a robust, accessible, integrated health information platform that supports the comprehensive management and exchange of biomedical data on a national scale. He is also Executive Director of the UCLA Wireless Health Institute. Ranked #65 on the Forbes 400 Richest Americans 2009 list, Patrick recently told CNBC.com that he wants to “completely change the mindset about healthcare,” motivating the industry to maintain health rather than to treat illness. Patrick’s significant achievements have been recognized internationally with numerous prestigious awards, including the J.W. Hyatt Award for Service to Mankind and, now, ABL’s highest honor.